Controlled tests on the worm model C. Elegans to delineate mechanisms operating in the mismatch repair (MMR) pathways may be relevant to humans as well and this knowledge could pave the way for newer approaches to cancer therapy according to a group of scientists from European Bioinformatics Institute (EMBL-EBI), the University of Dundee and the Wellcome Sanger Institute.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer